Company
United StatesPublic company, NASDAQ: INCYIncyte Corporation (NASDAQ: INCY), Wilmington, DE – FDA Inspections
Inspection records and compliance data for Incyte Corporation in Wilmington, Delaware. 11 FDA inspections on record, last inspected September 11, 2026. Publicly traded as NASDAQ: INCY.
Company Profile
This profile covers Incyte Corporation based in Wilmington, Delaware, United States.
FDA Inspection History
- FDA inspections
- 11
- OAI
- 0
- VAI
- 1
- NAI
- 8
- Unclassified
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected August 19, 2011. Last inspected September 11, 2026.
FDA inspections (11)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 11, 2026 | Not classified | Human Drugs | 1337612 |
| August 28, 2026 | Not classified | Human Drugs | 1333950 |
| September 23, 2025 | NAI | Human Drugs · Bioresearch Monitoring | 1272821 |
| November 18, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1194802 |
| November 15, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1157927 |
| April 16, 2021 | VAI | Human Drugs · Bioresearch Monitoring | 1140901 |
| February 10, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1118897 |
| November 28, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1073617 |
| April 27, 2016 | NAI | Human Drugs · Bioresearch Monitoring | 980787 |
| March 19, 2013 | NAI | Human Drugs · Bioresearch Monitoring | 822955 |
| August 19, 2011 | NAI | Human Drugs · Bioresearch Monitoring | 740200 |
FDA documents
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Incyte Corporation
Stock ticker
INCY
Exchange
NASDAQ
Share price
$121.70
Market cap
$24.8B
Price as of
November 13, 2026
FEI Number
3008992769
Address
1801 Augustine Cut Off, Wilmington, Delaware 19803, United States
Country
United States
ID: 2f3187b3-71fc-4c7d-95bf-d829cc4eceec